FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020618378> ?p ?o ?g. }

• W2020618378 abstract "A previously healthy French-born 13-month-old ethnically African girl, weighing 10 kg, travelled to Comoros (South-East Africa) on 10 July. Her family history was notable for an autistic brother and two other brothers in good health. Her parents are of African origin and are not related. She was prescribed pyrimethamine, 50 mg once daily (adult dosage), as an antimalaria chemoprophylaxis by her physician prior to this first visit to Comoros. Her parents supervised administration of this medication and stated that she missed no dose.On 23 July, she presented to a clinic in Comoros with hyperthermia and generalized clonic seizures, continuous for the first 5–6 h and then intermittent for 24 h. She was admitted to the intensive care unit in Comoros where she was treated for presumed cerebral malaria with intravenous quinine despite a negative malaria test. During the next 15 days, she had many recurrent crises, with continued confusion and digestive problems. Her fever abated on 31 August. She was brought back to France and hospitalized in the Department of Paediatric Neurology (Hopital Debrousse-Lyon-France). Search for Plasmodium and other microorganisms in the blood and in cerebral fluid were negative. She was discharged on 5 September with severe persistent neurological deficits. Cerebral magnetic resonance imaging performed on 6 September showed cortical and subcortical atrophy, and electroencephalograms showed the persistence of disturbed basic cortical activity.This adverse event was reported to the Lyon Pharmacovigilance Centre. A computerized prescribing error was suspected because the prescription was not handwritten. The prescribing physician, interviewed by telephone, confirmed that she has used Medigest, a drug management software.The principal indication for pyrimethamine in children is congenital toxoplasmosis, administered at a dose of 1 mg kg−1 day−1. Adverse effects occur with doses >20 mg kg−1 or with a recurrent dose >5 mg kg−1 day−1[1]. Seizures, coma and blindness have been reported [1–5]. Because of the high risk of severe neurological consequences and also Plasmodium resistance, pyrimethamine is no longer appropriate for the chemoprophylaxis of malaria [6].In this case, the prescribing physician searched the drug management software (Medigest) for the indication of malaria prophylaxis by entering ‘Mal’. When we searched the same computerized system for ‘Mal’, pyrimethamine and atovaquone-proguanil displayed next to each other. We first selected pyrimethamine with a default adult dosage. There was no alert indicating that pyrimethamine is no longer prescribed alone as a chemoprophlaxis for malaria. When the patient’s characteristics and the disease (presumed P. falciparum) were entered we were alerted that ‘the 50 mg tablet is only to be prescribed for adults’.The use of information technology (IT) in routine clinical care has been promoted in Europe and the USA to improve patient safety and practice efficiency [7]. IT has been shown to reduce medical errors and improve the quality of healthcare in certain circumstances [8]. However, error reduction and improved patient safety cannot be achieved if prescribing errors are not addressed [9].Many computerized order entry programs lack efficient alert systems to avoid overdoses, allergies, drug–drug interactions and contraindications or drugs unlaballed or unauthorized in children. IT solutions should provide physicians with reminders and alerts for evidence-based preventive care and disease management based on patient-specific drug, disease, and therapeutic information [9]." @default.
• W2020618378 created "2016-06-24" @default.
• W2020618378 creator A5012069487 @default.
• W2020618378 creator A5043841949 @default.
• W2020618378 creator A5065775479 @default.
• W2020618378 creator A5068935120 @default.
• W2020618378 creator A5073932439 @default.
• W2020618378 creator A5091690444 @default.
• W2020618378 date "2007-02-01" @default.
• W2020618378 modified "2023-09-30" @default.
• W2020618378 title "Safety of computerized drug management: a case report" @default.
• W2020618378 cites W1563530833 @default.
• W2020618378 cites W1971764542 @default.
• W2020618378 cites W1978715187 @default.
• W2020618378 cites W2015077708 @default.
• W2020618378 cites W2054335355 @default.
• W2020618378 cites W2107543779 @default.
• W2020618378 cites W2403608487 @default.
• W2020618378 cites W2404715542 @default.
• W2020618378 cites W2981617015 @default.
• W2020618378 doi "https://doi.org/10.1111/j.1365-2125.2006.02774.x" @default.
• W2020618378 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2000568" @default.
• W2020618378 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17274791" @default.
• W2020618378 hasPublicationYear "2007" @default.
• W2020618378 type Work @default.
• W2020618378 sameAs 2020618378 @default.
• W2020618378 citedByCount "2" @default.
• W2020618378 crossrefType "journal-article" @default.
• W2020618378 hasAuthorship W2020618378A5012069487 @default.
• W2020618378 hasAuthorship W2020618378A5043841949 @default.
• W2020618378 hasAuthorship W2020618378A5065775479 @default.
• W2020618378 hasAuthorship W2020618378A5068935120 @default.
• W2020618378 hasAuthorship W2020618378A5073932439 @default.
• W2020618378 hasAuthorship W2020618378A5091690444 @default.
• W2020618378 hasBestOaLocation W20206183782 @default.
• W2020618378 hasConcept C118552586 @default.
• W2020618378 hasConcept C126322002 @default.
• W2020618378 hasConcept C187212893 @default.
• W2020618378 hasConcept C197934379 @default.
• W2020618378 hasConcept C203014093 @default.
• W2020618378 hasConcept C2426938 @default.
• W2020618378 hasConcept C2777425658 @default.
• W2020618378 hasConcept C2777617192 @default.
• W2020618378 hasConcept C2778048844 @default.
• W2020618378 hasConcept C2778371730 @default.
• W2020618378 hasConcept C2780168130 @default.
• W2020618378 hasConcept C2908793570 @default.
• W2020618378 hasConcept C57658597 @default.
• W2020618378 hasConcept C71924100 @default.
• W2020618378 hasConcept C98274493 @default.
• W2020618378 hasConceptScore W2020618378C118552586 @default.
• W2020618378 hasConceptScore W2020618378C126322002 @default.
• W2020618378 hasConceptScore W2020618378C187212893 @default.
• W2020618378 hasConceptScore W2020618378C197934379 @default.
• W2020618378 hasConceptScore W2020618378C203014093 @default.
• W2020618378 hasConceptScore W2020618378C2426938 @default.
• W2020618378 hasConceptScore W2020618378C2777425658 @default.
• W2020618378 hasConceptScore W2020618378C2777617192 @default.
• W2020618378 hasConceptScore W2020618378C2778048844 @default.
• W2020618378 hasConceptScore W2020618378C2778371730 @default.
• W2020618378 hasConceptScore W2020618378C2780168130 @default.
• W2020618378 hasConceptScore W2020618378C2908793570 @default.
• W2020618378 hasConceptScore W2020618378C57658597 @default.
• W2020618378 hasConceptScore W2020618378C71924100 @default.
• W2020618378 hasConceptScore W2020618378C98274493 @default.
• W2020618378 hasLocation W20206183781 @default.
• W2020618378 hasLocation W20206183782 @default.
• W2020618378 hasLocation W20206183783 @default.
• W2020618378 hasLocation W20206183784 @default.
• W2020618378 hasOpenAccess W2020618378 @default.
• W2020618378 hasPrimaryLocation W20206183781 @default.
• W2020618378 hasRelatedWork W1591202245 @default.
• W2020618378 hasRelatedWork W1983544050 @default.
• W2020618378 hasRelatedWork W2124466768 @default.
• W2020618378 hasRelatedWork W2125138090 @default.
• W2020618378 hasRelatedWork W2564299030 @default.
• W2020618378 hasRelatedWork W2794783788 @default.
• W2020618378 hasRelatedWork W2794786052 @default.
• W2020618378 hasRelatedWork W2899084033 @default.
• W2020618378 hasRelatedWork W4213271907 @default.
• W2020618378 hasRelatedWork W4226515308 @default.
• W2020618378 isParatext "false" @default.
• W2020618378 isRetracted "false" @default.
• W2020618378 magId "2020618378" @default.
• W2020618378 workType "article" @default.